Delivery Order SPE2DB20D3103-SPE2DB22FL3Y0
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,341.58 firm fixed-price delivery order is for the supply of AVAPRO 150 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of October 17, 2023 and was awarded on October 16, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of AVAPRO 150 MG TABLET 30S. The contract is a Delivery Order under the existing Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $1,316.88 and is for the delivery of AVAPRO 150 MG TABLET 30S, a generic medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical. This IDC serves as a...
- This federal contract award is for the delivery of AVAPRO 75 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,172.59, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,228.20 fixed-price delivery order contract is for the supply of AVAPRO 300 MG TABLET 30S, a medication used to treat hypertension. The contract has an ultimate completion date of April 19, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,769.18 firm fixed-price contract is for the delivery of AVAPRO 300 MG TABLET 30S, a cardiovascular medication, with a period of performance through November 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Irbesartan 150 mg tablets. The $5,275.08 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the DLA Troop Support Medical and the vendor's parent company, Cencora, Inc. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Irbesartan 150 mg tablets. The fixed-price delivery order, valued at $3,303.32, has a period of performance through February 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,432.74, is for the delivery of Irbesartan 300 mg tablets. The contract has an ultimate completion date of January 16, 2025 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $1,888.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Irbesartan 300 mg tablets, a cardiovascular medication, over the period ending on April 2, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FL3Y0Delivery Order
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,985.78, is for the delivery of AVAPRO 150 MG TABLET 30S, a prescription medication. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that specializes in the distribution of a wide range of pharmaceutical products and medical supplies to various government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The contract award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 10/19/21 |